Inscripta
Business Services · Colorado, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5500 Central Ave Ste 220, Boulder, Color...Phone Number
(720) 759-4088Website
www.inscripta.comRevenue
$29.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
2
1
1
About Inscripta
Inscripta is developing the world's first benchtop platform for scalable digital genome engineering. The company's advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel, trackable editing of single cells at unprecedented scale. Inscripta was established in 2015 and is headquartered in Boulder, Colorado, United States.Explore more
Inscripta Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inscripta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Inscripta launches new products
Congratulate Masked Content for being promoted to Masked Content at Inscripta
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Inscripta recently announced quarterly report
Funding: Get notified immidiatlly once Inscripta has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Inscripta had a recent Job posting/layoffs
Check out if Inscripta is spiking on competitors!
Inscripta, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Inscripta has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Inscripta as Masked Content
Find 3 more new buyers
Compare Similar Companies to Inscripta
Compare insights from companies similar to Inscripta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Inscripta is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Inscripta is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Inscripta.
Inscripta financials insights
Gather financial insights about Inscripta, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$6M
2017
Series B
$23M
2018
Series C
$55.5M
2019
Series D
$125M
2020
Unspecified
$58M
2021
Series E
$150M
Inscripta Tech Stack
A closer look at the technologies used by Inscripta
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Person-Based
Inscripta News & Media
Morgan Lewis Advises Manus in Merger Agreement with Inscripta
Morgan Lewis is advising Manus, a leading bioalternatives scale-up platform, on a strategic merger agreement with life sciences technology company Inscripta.INSCRIPTA® ANNOUNCES BIOMANUFACTURING OF A RAPIDLY GROWING ANTI-AGING SKINCARE INGREDIENT
INSCRIPTA ACHIEVES IMPORTANT MILESTONE AND DEMONSTRATES ITS NOVEL WHOLE GENOME ENGINEERING BIOTECHNOLOGY PLATFORM WITH ACCELERATED TIMELINES PLEASANTON, Calif., Nov. 7, 2024 /PRNewswire/ -- Inscripta, Inc., a leading life science technology company helping to create the bioeconomy, has...Inscripta Is Reimagining What The Synthetic Biology Company Of The Future Will Be
Inscripta, Inc. , a global leader in genome engineering, is reimaging what a #syntheticbiology company model looks like. Instead of trying to hack biology using brute force, they are proposing a more lean & efficient approach to making bioproducts.INSCRIPTA® ACQUIRES INFINOME BIOSCIENCES AND SESTINA BIO TO ADVANCE SUSTAINABLE BIOMANUFACTURING
PLEASANTON, Calif., Jan. 18, 2023 /PRNewswire/ -- Inscripta, a global leader in genome engineering technology, announced today the acquisition of two pioneers of synthetic biology – Infinome Biosciences and Sestina Bio, which advance Inscripta's strategy to develop and commercialize...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Inscripta
Sign Up For FreeTo access detailed company insights
Inscripta is developing the world's first benchtop platform for scalable digital genome engineering. The company's advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel, trackable editing of single cells at unprecedented scale. Inscripta was... Read More
